Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Denali Therapeutics Inc. buy BiotechBee

Denali Therapeutics Inc.
Start price
€23.00
08.09.24 / 70%
Target price
€31.00
30.05.27
Performance (%)
-4.35%
End price
€22.00
14.12.24
Summary
This prediction ended on 14.12.24 with a price of €22.00. With a performance of -4.35%, the BUY prediction for Denali Therapeutics Inc. by BiotechBee closed slightly in the red. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Denali Therapeutics Inc. -1.631% -1.631% 70.105%
iShares Core DAX® 0.437% 5.640% 7.806%
iShares Nasdaq 100 1.057% 0.282% 27.239%
iShares Nikkei 225® 1.769% 0.406% 49.266%
iShares S&P 500 0.368% 1.920% 22.336%

According to BiotechBee what are the pros and cons of Denali Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Denali Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -4.35%
Target price 31.000
Change
Ends at 30.05.27

Buy mit Kursziel 31,0

BiotechBee 
0
Report Share
08.09.24
In the thread Trading Denali Therapeutics Inc.
Prediction Buy
Perf. (%) -4.35%
Target price 31.000
Change
Ends at 30.05.27

Buy beendet

BiotechBee 
0
Report Share
14.12.24